Skip to main content
Clinical Trials/NCT01489150
NCT01489150CompletedNot Applicable

Use of EtCO2 and Prolonged Expiratory Maneuvers as a PaCO2 Predictor in Cases of Acute Hypercapnic Respiratory Failure

University of Lausanne Hospitals1 site in 1 country11 target enrollmentStarted: December 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
11
Locations
1
Primary Endpoint
Comparison between EtCO2,PaCO2 and PaCO2 variation under NIV during both spontaneous expiration and prolonged expiration

Study Overview

Brief Summary

In patients treated by Non invasive ventilation (NIV) due to acute hypercapnic respiratory failure, the interest of using the End-tidal Co2 measurement device "Capnostream" to evaluate PaCo2 and PaCo2 variations over time will be evaluated. Measurements will be done under normal expiration and under prolonged active and passive expiration maneuvers.

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • ICU patient equipped with arterial line
  • NIV requirement
  • Hypercapnia: PaCO2 > 45mmhg

Exclusion Criteria

  • Severe hemodynamic instability
  • Severe psychiatric disorders
  • nasal lesions
  • denied consent

Outcomes

Primary Outcomes

Comparison between EtCO2,PaCO2 and PaCO2 variation under NIV during both spontaneous expiration and prolonged expiration

Time Frame: Sixty minutes

Comparison between EtCO2,PaCO2 and PaCO2 variation under NIV during both spontaneous expiration and prolonged expiration

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
University of Lausanne Hospitals
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Prof. Philippe Jolliet

Principal investigator

University of Lausanne Hospitals

Study Sites (1)

Loading locations...

Similar Trials